A Delphi consensus study on salvage brachytherapy for prostate cancer relapse after radiotherapy, a Uro-GEC study.

Published on Jan 1, 2016in Radiotherapy and Oncology4.856
· DOI :10.1016/J.RADONC.2015.10.021
Emmie Kaljouw3
Estimated H-index: 3
(UvA: University of Amsterdam),
Bradley R. Pieters17
Estimated H-index: 17
(UvA: University of Amsterdam)
+ 1 AuthorsPeter Hoskin94
Estimated H-index: 94
Sources
Abstract
Abstract Background and purpose Patients treated with low radiotherapy dose or treated at young age are at a risk of developing local relapse. Although data are preliminary, brachytherapy seems an attractive treatment option for recurrent prostate cancer after previous radiotherapy. Therefore, the UroGEC group of the GEC-ESTRO conducted a Delphi study, to explore expert opinion on the management of salvage prostate brachytherapy. Material and methods For this study, a series of digital questionnaires were sent, which enabled data collection from an international group of experienced participants. Consensus was defined as 80% agreement for each question. Results Eighteen experts completed all rounds of the Delphi study. After the final round consensus was reached on 17 out of 38 (45%) questions. Consensus was reached in 52% of questions about patient selection, in 50% of the questions about diagnostic tests and in 22% of the questions on performing salvage prostate brachytherapy. Conclusions The group was able to find consensus on less than half of the questions. Most consensus was reached on topics involving patient selection and diagnostic tests, where participants could build on their experience of daily practice. However, the way to perform the salvage treatment is less established and results in more disagreement between participants.
📖 Papers frequently viewed together
100 Citations
125 Citations
43 Citations
References51
Newest
#1Jim RoseH-Index: 4
#2Juanita CrookH-Index: 58
Last. W. James MorrisH-Index: 28
view all 5 authors...
Abstract Purpose Rates of late toxicity are higher for salvage treatment of local recurrence after prior radiotherapy. We present our experience with salvage prostate brachytherapy (BT) for local recurrence after definitive external beam radiotherapy with attention to the relationship between dose and late toxicity. Methods and Materials From 2005 to 2012, 18 patients with biopsy proven locally recurrent prostate cancer and negative staging received low-dose-rate BT with a prescribed dose of 130...
21 CitationsSource
8 CitationsSource
Abstract Even in the current era of dose-escalated radiotherapy for prostate cancer, biochemical recurrence is not uncommon. Furthermore, biochemical failure is not specific to the site of recurrence. One of the major challenges in the management of prostate cancer patients with biochemical failure after radiotherapy is the early discrimination between those with locoregional recurrence only and those with metastatic disease. While the latter are generally considered incurable, patients with loc...
38 CitationsSource
#1William M. Mendenhall (UF: University of Florida)H-Index: 109
#2Randal H. HendersonH-Index: 20
Last. Nancy P. MendenhallH-Index: 66
view all 5 authors...
: Although a significant proportion of patients with localized prostate cancer are cured after definitive radiotherapy, solitary local recurrence is observed in a subset of patients and poses a management challenge. Curative-intent treatment options include prostatectomy, reirradiation, cryotherapy, and high-intensity-focused ultrasound. Outcomes data after any of these options are relatively limited. The 5-year biochemical progression-free survival rate is approximately 50% after salvage prosta...
7 CitationsSource
#1Max Peters (UU: Utrecht University)H-Index: 13
#2M. Maenhout (UU: Utrecht University)H-Index: 9
Last. Marco van Vulpen (UU: Utrecht University)H-Index: 44
view all 8 authors...
Purpose Whole-gland salvage for recurrent prostate cancer (PCa) shows high failure and toxicity rates. Early and adequate localization of recurrences enables focal salvage, thereby potentially improving functional outcomes, while maintaining cancer control. Materials and methods Retrospective analysis yielded 20 focal salvage I125 brachytherapy patients for locally recurrent PCa after primary radiotherapy. Tumor was defined by multiparametric MRI and correspondence with transrectal biopsies. Dos...
69 CitationsSource
#1Guohua Shen (Sichuan University)H-Index: 11
#2Houfu Deng (Sichuan University)H-Index: 7
Last. Zhiyun Jia (Sichuan University)H-Index: 6
view all 4 authors...
Published data on the diagnosis of bone metastases of prostate cancer are conflicting and heterogeneous. We performed a comprehensive meta-analysis to compare the diagnostic performance of choline-PET/CT, MRI, bone SPECT, and bone scintigraphy (BS) in detecting bone metastases in parents with prostate cancer. Pooled sensitivity, specificity, and diagnostic odds ratios (DOR) were calculated both on a per-patient basis and on a per-lesion basis. Summary receiver operating characteristic (SROC) cur...
204 CitationsSource
#1György Kovács (University of Lübeck)H-Index: 22
#2Jean-Marc CossetH-Index: 1
Last. Brendan CareyH-Index: 1
view all 3 authors...
Purpose of reviewFocal radiotherapy treatment procedures play an increasingly important role in function-preservation and organ-preservation treatment techniques. As an alternative to traditional whole-gland radiotherapy regimes, focal prostate radiotherapy may be of benefit for both primary tumor a
12 CitationsSource
#1Ivan HenriquezH-Index: 12
#2G. SanchoH-Index: 8
Last. Alfredo PoloH-Index: 16
view all 10 authors...
Purpose: To evaluate efficacy and toxicity after salvage brachytherapy (BT) in prostate local recurrence after radiation therapy. Methods and materials: Between 1993 and 2007, we retrospectively analyzed 56 consecutively patients (pts) undergoing salvage brachytherapy. After local biopsy-proven recurrence, pts received 145 Gy LDR-BT (37 pts, 66%) or HDR-BT (19 pts, 34%) in different dose levels according to biological equivalent doses (BED 2G y). By the time of salvage BT, only 15 pts (27%) rece...
43 CitationsSource
#1Ivan Diamond (U of T: University of Toronto)H-Index: 67
#2Robert C. GrantH-Index: 3
Last. Paul W. Wales (U of T: University of Toronto)H-Index: 42
view all 7 authors...
Abstract Objective To investigate how consensus is operationalized in Delphi studies and to explore the role of consensus in determining the results of these studies. Study Design and Settings Systematic review of a random sample of 100 English language Delphi studies, from two large multidisciplinary databases [ISI Web of Science (Thompson Reuters, New York, NY) and Scopus (Elsevier, Amsterdam, NL)], published between 2000 and 2009. Results About 98 of the Delphi studies purported to assess con...
769 CitationsSource
#1Carlos VargasH-Index: 25
#2Douglas A. SwartzH-Index: 16
Last. Mitchell TerkH-Index: 6
view all 9 authors...
Abstract Purpose To evaluate the role of salvage prostate brachytherapy for locally recurrent prostate cancer after external beam radiation alone. Methods and Materials Sixty-nine consecutive patients treated with salvage brachytherapy after a local failure were analyzed. All patients were found to have pathologic proven recurrent prostate cancer at least 2 years after initial therapy and no regional or distant disease on imaging studies. Pd-103 was used with a prescribed p D 90 of 100 Gy. In to...
36 CitationsSource
Cited By27
Newest
#1David BuchserH-Index: 4
Last. Felipe Couñago (UEM: European University of Madrid)H-Index: 8
view all 9 authors...
Although dose escalation protocols have improved biochemical control in prostate cancer radiotherapy, 10-45% of patients will experience disease recurrence. The prostate and seminal vesicles are the most frequent site of the first relapse. Traditionally, these patients have been managed with hormonal therapy, which is not curative. Recent improvements in diagnostic tests (e.g., multiparametric magnetic resonance and molecular imaging, including PET/CT scan with choline or Ga-PSMA) and new treatm...
Source
#2Giulia MarvasoH-Index: 14
Last. Piet OstH-Index: 41
view all 36 authors...
Abstract Background and purpose Between 30% and 47% of patients treated with definitive radiotherapy (RT) for prostate cancer are at risk of intraprostatic recurrence during follow-up. Re-irradiation with stereotactic body RT (SBRT) is emerging as a feasible and safe therapeutic option. However, no consensus or guidelines exist on this topic. The purpose of this ESTRO ACROP project is to investigate expert opinion on salvage SBRT for intraprostatic relapse after RT. Materials and Methods A 40-it...
3 CitationsSource
#1Fernando MunozH-Index: 11
#2Francesco FioricaH-Index: 16
Last. Mariangela Massaccesi (CUA: The Catholic University of America)H-Index: 16
view all 15 authors...
Abstract Aims The best therapeutic approach for local relapses of previously irradiated prostate cancer (PC) is still not defined. Re-irradiation (Re-I) could offer a chance of cure for highly selected patients, although high quality evidences are lacking. The aim of our study is to provide a literature review on efficacy and safety of Re-I. Methods Only studies where Re-I field overlaps with previous radiotherapy were considered. To determine 2 and 4 years overall mortality (OM), 2 and 4 years ...
4 CitationsSource
#1Jim Zhong (University of Leeds)
#2F. Slevin (University of Leeds)H-Index: 3
Last. Ann HenryH-Index: 32
view all 8 authors...
Source
#1Francesco CucciaH-Index: 7
#2Rosario MazzolaH-Index: 19
Last. Filippo Alongi (University of Brescia)H-Index: 33
view all 10 authors...
INTRODUCTION To date, the optimal management of locally relapsed prostate cancer patients after an initial course of radiotherapy remains a matter of debate. In recent years, local approaches have been proposed as a therapeutic option, which may potentially delay the initiation of hormone therapy. In the case of external beam radiotherapy (EBRT), re-irradiation has been supported by growing evidence in the literature, mostly represented by extreme hypofractionated schedules delivered with stereo...
5 CitationsSource
#1V. Karahissarlian (Argonne National Laboratory)H-Index: 1
#2Paul Sargos (JGH: Jewish General Hospital)H-Index: 18
Last. L. Thomas (Argonne National Laboratory)H-Index: 8
view all 11 authors...
Abstract Purpose The purpose of this study was to evaluate MRI and fluorocholine PET/CT diagnostic performances for the detection of local recurrence following prostate brachytherapy for localised prostate cancer. Material and methods In this single-centre study, we retrospectively reviewed data from 21 patients treated by brachytherapy for localised prostate cancer and diagnosed with biochemical recurrence according to Phoenix Criteria, who underwent MRI and fluorocholine PET/CT. We included pa...
1 CitationsSource
#1F. Slevin (University of Leeds)H-Index: 3
#2Samantha Hodgson (Leeds Teaching Hospitals NHS Trust)H-Index: 1
Last. Ann Henry (University of Leeds)H-Index: 32
view all 12 authors...
Abstract Introduction Isolated local recurrence of prostate cancer following primary radiotherapy or brachytherapy may be treated with focal salvage high dose rate brachytherapy, although there remains an absence of high quality evidence to support this approach. Methods Men with prostate cancer treated consecutively between 2015 and 2018 using 19 Gy in a single fraction high dose rate brachytherapy (HDR) for locally recurrent prostate cancer were identified from an institutional database. Univa...
6 CitationsSource
#1Dario Zerini (IEO: European Institute of Oncology)H-Index: 17
#2Barbara Alicja Jereczek-Fossa (IEO: European Institute of Oncology)H-Index: 4
Last. Filippo Alongi (University of Brescia)H-Index: 33
view all 14 authors...
PURPOSE We herein present the results of the first Italian Association of Radiotherapy and Clinical Oncology (AIRO) survey regarding salvage external beam re-irradiation of local prostate cancer relapse named PROLAPSE. METHODS A questionnaire with 12 items was administered to the 775 Italian radiation oncologist members of the AIRO. RESULTS One hundred of the members completed the survey. The survey highlighted that 59% of the participants are currently performing prostate re-EBRT, while nearly ...
4 CitationsSource
#1Gokhan Ozyigit (Hacettepe University)H-Index: 19
#2Pervin Hurmuz (Hacettepe University)H-Index: 8
Last. Fadil Akyol (Hacettepe University)H-Index: 18
view all 7 authors...
Abstract Purpose The optimal management of locally recurrent prostate cancer after curative radiotherapy is still unknown. In this study, we evaluated the preliminary results of reirradiation using stereotactic body radiotherapy for locally recurrent prostate cancer after initial definitive local radiotherapy. Materials and methods Between April 2016 and February 2019, 11 patients with recurrent disease at the previously irradiated prostate were treated. Local recurrence was detected by radiolog...
Source
#1Francesco CucciaH-Index: 7
#2Luca NicosiaH-Index: 11
Last. Filippo Alongi (University of Brescia)H-Index: 33
view all 11 authors...
BACKGROUND AND OBJECTIVE: The optimal management of prostate cancer (PC) recurrences after definitive or postoperative radiotherapy (RT) is still controversial. The aim of the present retrospective study was to report the preliminary clinical results and toxicity of a mono-institutional series of patients re-irradiated with linac-based SBRT in recurrent prostate cancer. METHODS: Inclusion criteria were previous definitive or adjuvant/salvage RT, evidence of biochemical recurrence and radiologica...
7 CitationsSource